Robert Q. Herzberg, PhD

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Contributor: Finding the Missing Patient in Value-Based Care

Reaction Mixed After CMS Unveils Negotiated Medicare Drug Prices

Managing Germline Mutations in Hereditary Breast Cancer Risk

Introduction and Current Landscape of HER2 in NSCLC